Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AXSM
AXSM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AXSM News
Biotech Stocks Outperform S&P 500 in H1 2026
1d ago
Fool
Biotech Companies Reach Critical Turning Point
1d ago
NASDAQ.COM
Axsome Therapeutics Shows Significant Growth Potential
6d ago
Fool
Axsome's Auvelity Approved for Alzheimer's Agitation Treatment
6d ago
NASDAQ.COM
Tarsus Accused of Market Manipulation by Culper Research
6d ago
stocktwits
Axosome Initiates Phase 3 Trial for Solriamfetol in ADHD Treatment
Jun 26 2026
NASDAQ.COM
Axsome Initiates Phase 3 Trial for ADHD Treatment
Jun 26 2026
Newsfilter
Axsome Promotes Alzheimer's Awareness During Awareness Month
Jun 18 2026
Newsfilter
Three Innovative Biotechs with Promising Prospects
Jun 16 2026
NASDAQ.COM
Analysis of Three Promising Biotech Companies
Jun 16 2026
Fool
Axsome Presents New SYMBRAVO Data at AHS Meeting
Jun 04 2026
Newsfilter
Axsome Therapeutics Settles Patent Litigation for SUNOSI
Jun 04 2026
NASDAQ.COM
Axsome Therapeutics Settles Patent Lawsuits for Sunosi
Jun 03 2026
seekingalpha
Axsome Resolves SUNOSI Patent Litigation, Opens Generic Market
Jun 03 2026
Newsfilter
Healthcare Transformation: The Rise of Data-Driven Models
May 08 2026
Fool
Tempus AI and Others Poised to Transform Precision Medicine
May 08 2026
NASDAQ.COM
Show More News
